Study seeks optimal ephedrine dose for Infants' low blood pressure during surgery
NCT ID NCT02384876
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested different doses of the drug ephedrine to find the most effective one for treating low blood pressure that occurs during surgery in newborns and infants up to 6 months old. The trial involved 120 infants who developed low blood pressure while under anesthesia. Researchers compared several higher doses against a standard low dose to see which worked best.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ephedrine
- What this could lead to
- If successful, this could establish a safer, more effective dose of ephedrine for treating low blood pressure during surgery in very young infants.
- What could go wrong
- This is a small, early-phase study (Phase 2) with only 120 participants, so results may not apply to all infants. The study is also completed, so no new data is being collected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
120 people
The number who actually took part.
- Started
-
Jun 2015
- Finished
-
Sep 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Up to 6 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Newborns or infants \< 6 months of age, * boys and girls, * premature or not, * requiring general anesthesia induced by sevoflurane * who presents during anesthesia a decrease of blood pressure superior to 20% of the basal mBP (measured prior to surgery) despite of vascular filling with sodium chloride 0.9% (10mL/kg during 10 min). * Written, informed consent obtained from the 2 parents Exclusion Criteria: * Allergy to Ephedrine. * Emergency surgery. * Patient having previously received other vasopressive amines. * Use of other indirect sympathomimetic drug such as phenylpropanolamine, phenylephrine, pseudoephedrine and methylphenidate. * Premedication with clonidine * Congenital heart disease * IV-induced anesthesia.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infant, newborn are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospices Civils de Lyon
Lyon, France
-
Hôpital Nord
Saint-Etienne, 42055, France
-
Hôpital d'Estaing
Clermont-Ferrand, 63003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breast milk from donors vs. formula: which builds a better brain for tiny babies?
- Gentler resuscitation may protect fragile lungs in tiniest babies
- Nasal fentanyl spray could ease painful eye exams for premature babies
- Brain blood flow in tiny patients: study seeks safe surgery limits
- Massive study tracks tiny babies to unlock secrets of early development
- Waiting 30 seconds to clamp the cord could help tiniest babies